Medicquant

Rapid answers for life-saving treatment

MedicQuant has invented the first-in-class technology to measure small molecule drug concentrations in whole blood at the point-of-care.
The breakthrough platform technolology will enable life-saving therapies and be a critical tool for precision medicine.

Our first product focuses on point-of-care testing for Direct Oral Anticoagulants (DOACs) in emergency setting, designed to save lives and improve healthcare efficiency.

Need is expressed by Key Opinion Leaders in the field

It would be very impactful if DOAC drug levels were available at the point-of-care in 10 minutes.

‍

Feedback from the US, Director of Hemophilia and Thrombosis

DOAC levels are the only thing we wait for currently before thrombolysis. A point-of-care DOAC test could be a game changer in acute stroke treatment.

‍

Feedback from the UK, Consultant Neurologist, Hyper-acute stroke unit

The only thing we wait for is the DOAC levels in order to treat stroke patients on DOACs. We need a rapid test for DOACs, today rather than tomorrow.

Feedback from DK, Chief physician, Department of Neurology

Technology

Lab-grade diagnostics in under 10 minutes

MedicQuant is a spin-out from Aarhus University, Denmark, and stand on the foundation of more than 10 years of state-of-the-art research. Our innovative technology is built on the proprietary, patent-pending platform using DNA nanotechnology, designed for precise measurement of small molecules. This innovative system delivers diagnostic accuracy comparable to laboratory standards in just 10 minutes directly from a whole blood sample.

While the assays are currently being developed for anticoagulants, the platform allows for easy adaptation to other small molecules. We have already demonstrated proof of concept for antibiotics, anticancer drugs, and antirheumatic drugs, among others.
‍
The novel cartridge system, also patent-pending, generates signals with minimal user handling and can process complex media such as whole blood. Usability studies conducted with end users at relevant sites have rated the system as "easy" or "very easy" to use.

Fast

Results in just 10 minutes enabling immediate decision-making

Point-of-care

Compact, reliable and easy-to-use in any emergency departments

Precise

Diagnostic accuracy comparable to laboratory standards

Invest in MedicQuant

We are currently fundraising

We are raising our second equity round, and looking for new investors to join our existing investors.
‍
Please contact us for investor deck and further information.

Backed by